Publications by authors named "G Engholm"
Article Synopsis
- The study aimed to assess if improvements in lung cancer survival from 1990 to 2016 were consistent across different age groups and cancer types in Nordic countries.
- Data from Denmark, Finland, Iceland, Norway, and Sweden was analyzed, showing continuous improvements in both 1- and 5-year relative survival rates for lung cancer across all demographics and subtypes, with Denmark seeing the most significant improvements.
- Despite these advancements, lung cancer survival rates are still low, with around 75% of patients dying within five years of diagnosis.
Background And Purpose: Stage at cancer diagnosis is an important predictor of cancer survival. TNM stage is constructed for anatomic solid cancer diagnoses from tumor size (T), nodal spread (N) and distant metastasis (M) and categorized in groups 0-I, II, II and IV. TNM stage is imperative in cancer diagnosis, management and control, and of high value in cancer surveillance, for example, monitoring of stage distributions.
View Article and Find Full Text PDFMost Western countries have increasing number of new cancer cases per year. Cancer incidence is primarily influenced by basically avoidable risk factors and an aging population. Through hypothetical elimination scenarios of multiple major risk factors for cancer, we estimated the number of new cancer cases that are non-preventable in 2050.
View Article and Find Full Text PDFBackground: Since the early 2000s, overall and site-specific cancer survival have improved substantially in the Nordic countries. We evaluated whether the improvements have been similar across countries, major cancer types, and age groups.
Material And Methods: Using population-based data from the five Nordic cancer registries recorded in the NORDCAN database, we included a cohort of 1,525,854 men and 1,378,470 women diagnosed with cancer (except non-melanoma skin cancer) during 2002-2021, and followed for death until 2021.
Background: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements are observed in all ages and for both women and men.
Methods: Patients diagnosed with CMM in the Nordic countries in 1990-2016 were identified in the NORDCAN database.